Non-AIDS defining malignancies, particularly colorectal cancer (CRC), may be more prevalent among persons living with HIV (PLWH). Further, PLWH may be less likely to receive CRC screening (CRCS). We studied the epidemiology of CRC and CRCS patterns in PLWH and HIV-uninfected persons in a large US Medicaid population. We performed a matched cohort study examining CRC incidence in and CRCS between 1999. Study participants were continuously enrolled in the Medicaid programs of California, Florida, New York, Ohio, and Pennsylvania. All PLWH enrollees were matched to five randomly sampled HIV-uninfected enrollees on 5-year age group, gender, and state. Adjusted odds ratios (AORs) for incident CRC (adjusted for comorbidity index) and the presence of CRCS (adjusted for comorbidity index and years in the data-set) among PLWH compared to HIV-uninfected enrollees were calculated. PLWH were not more likely to be diagnosed with CRC after adjusting for comorbidity index (unadjusted OR: 1.73, 95% confidence interval [CI]: 1.37-2.19; AOR 1.29; 95% CI: 0.98-1.70). While CRCS rates were low overall, PLWH were more likely to have received CRCS in unadjusted analyses (35.8% vs. 33.7%; OR 1.10, 95% CI: 1.07-1.13). This relationship was reversed after adjusting for comorbidity index and years in the data-set (AOR: 0.80, 95% CI: 0.77-0.83). Limitations of the study include a focus on the Medicaid population, an inability to detect fecal occult blood tests (FOBT), and having half of patients between 50 and 55 years of age. In conclusion, PLWH were not more likely to be diagnosed with CRC, but in adjusted analyses, were less likely to have received CRCS. As we showed a low rate of CRCS overall in this Medicaid population, researchers, clinicians, and policy-makers should improve access to and uptake of CRCS among all Medicaid patients, and particularly among PLWH.
Introduction
As persons living with HIV (PLWH) live longer in the highly active antiretroviral therapy (ART) era, they become more susceptible to the development of chronic diseases and cancers. Since the introduction of ART in 1995, the incidence of AIDS-defining malignancies (ADM) has declined. However, there is evidence that non-ADMs are rising rapidly and disproportionately in PLWH relative to the general population (Engels et al., 2008; Frisch, Biggar, Engels, Goedert, & AIDS-Cancer Match Registry Study Group, 2001; Patel et al., 2008; Silverberg et al., 2011) .
Colorectal cancer (CRC) is the second leading cause of cancer death in the USA among malignancies that affect both men and women (US Cancer Statistics Working Group, 2013) . Studies looking at colorectal cancer risk in PLWH have been mixed. Some studies have shown that compared to HIV-uninfected individuals, PLWH may have worse survival (Berretta et al., 2009 ), more advanced disease at presentation (Bini, Green, & Poles, 2009 ), more neoplasms (Bini et al., 2009) , a diagnosis at an earlier age (Kumar et al., 2012; Wasserberg, Nunoo-Mensah, Gonzalez-Ruiz, Beart, & Kaiser, 2007) , or increased rates of CRC (Patel et al., 2008) . Other studies have shown that PLWH either have no difference in incidence of CRC (Silverberg et al., 2011) or a lower incidence of CRC (Engels et al., 2008; Frisch et al., 2001; Silverberg et al., 2011; Van Leeuwen et al., 2009 ) than HIV-uninfected individuals.
For those at average risk for CRC, the current US guidelines for CRC screening (CRCS) recommend that patients over 50 years of age have either a fecal occult blood test (FOBT) every year, sigmoidoscopy, or barium enema every 5 years with FOBT every 3 years, or colonoscopy every 10 years (Whitlock, Lin, Liles, Beil, & Fu, 2008) . Screening is underutilized: in 2010, only 64.5% of respondents aged 50-75 years nationwide reported having had one of these recommended screening measures within the allotted interval (Joseph, King, Miller, Richardson, & Centers for Disease Control and Prevention, 2012) . Guidelines for PLWH recommend following standard CRCS recommendations (Phillips & Justman, 2009 ), but studies suggest that PLWH may be less likely to receive CRCS (Campbell & Young, 2008; Iqbal, Browne-McDonald, & Cerulli, 2010; Momplaisir, Long, Badolato, & Brady, 2012; Reinhold, Moon, Tenner, Poles, & Bini, 2005) .
There is a strong evidence that many non-ADMs are increased in PLWH when compared with the general population. It is still unclear whether PLWH are at increased risk for CRC than those without HIV. Understanding this is important to determining whether current screening recommendations should be revised for PLWH. Medicaid is the nation's principal safety-net health insurance program, financing health for 62 million low-income Americans (Centers for Medicare and Medicaid Services [CMS], Office of the Actuary, 2013). Medicaid is also the single largest source of coverage for PLWH in the USA, covering an estimated 200,000-240,000 PLWH (Bozzette et al., 1998; CMS, 2013) . Relatively little is known about CRCS in Medicaid populations, although it appears to be lower than in the general population (DuBard, Schmid, Yow, Rogers, & Lawrence, 2008) . Thus, we sought to evaluate the epidemiology of CRC and CRCS usage in a Medicaid population of PLWH and persons without HIV, hypothesizing that PLWH are at higher risk of developing CRC, and that PLWH are less likely than those without HIV to undergo CRCS.
Methods

Data source
The Medicaid program consists of state-run programs with joint federal and state funding for hospital care, medical care, outpatient care, and drug benefits for lowincome and special-needs individuals (CMS, 2013) . Medicaid claims data were obtained on beneficiaries in five states (California, Florida, New York, Ohio, and Pennsylvania) chosen primarily for their large populations overall and large numbers of Medicaid enrollees. In these five states, 24 million persons are actively enrolled in Medicaid, representing 38% of the US Medicaid population (Kaiser Family Foundation [KFF], 2011). Medicaid claims report demographic information, inpatient and outpatient medical diagnoses (recorded by using International Classification of Diseases, Ninth Revision [ICD-9], diagnosis codes), and medications dispensed (CMS, 2013) . Since 17% of Medicaid beneficiaries are coenrolled in Medicare, we obtained Medicare data on dually eligible persons (CMS, 2013) . The University of Pennsylvania Institutional Review Board reviewed and approved the protocol, and a data use agreement was obtained from CMS.
Eligibility criteria
We performed a retrospective matched cohort study of California, Florida, New York, Ohio, and Pennsylvania state Medicaid programs. Medicare data was merged into the analytic file for those who were identified as dually eligible for Medicare and Medicaid. To verify enrollment in Medicaid, eligible participants had to have at least one claim in both 2004 and 2005. Those with a CRC diagnosis prior to 2006 were excluded from the data-set.
From the base analytic file, we created two subfiles to analyze CRC incidence and CRCS. For both subfiles, a stratified random sample of HIV-uninfected patients was matched to a stratified random sample of PLWH in a five-to-one ratio on gender, 5-year age group, and state. For the subfile to analyze CRC incidence, patients were eligible if they were at least 40 years of age on 1 January 2006. For the subfile to analyze CRCS, patients were eligible if they were between the ages of 50 and 75 on 1 January 2006.
Variable definitions
Patients were considered to have HIV if they had an ICD-9 code for HIV or AIDS and a prescription for an antiretroviral medication prior to 1 January 2006. Fultz et al. (2006) showed that this algorithm had a sensitivity of 90.4% and a specificity of 99.9% for HIV diagnosis. Age was calculated as the age of patients on 1 January 2006. Age within each 5-year age group (e.g., 40-44, 45-49, 50-54, 55-59, etc.,) was coded as a continuous variable. Race codes were abstracted from Medicaid and were coded as white race, black race, Hispanic ethnicity (regardless of race), or other race/ethnicity, with white as the referent race/ethnicity group. Numbers of years in the data-set was calculated from the first claim to the final claim. Numbers of diagnoses coded were calculated and dichotomized as greater than or lesser than 120 codes. Comorbidity scores were based on Chronic Illness Disability Payment System (CDPS) scores and ranged from 1 to 33. CDPS scores are based on weighted ICD-9 codes and have been validated in Medicaid data-sets (higher scores are associated with higher health services utilization) (University of California, San Diego [UCSD], 2012). Comorbidity scores were calculated based on the participant's first six months in the dataset, with codes reflective of HIV or AIDS removed.
To determine if patients had incident CRC, we used an algorithm that had been validated by Setoguchi et al. (2007) with Medicare data that was associated with 80.36% sensitivity and 99.51% specificity for incident CRC. Using this algorithm, patients were considered to AIDS Care 717 have incident CRC if they had a new Common Procedural Terminology (CPT) code or ICD-9 code for CRC in 2006 and none prior to 2006.
Patients were considered to have received CRCS if they had a CPT code for a sigmoidoscopy, colonoscopy, or barium enema between 1 January 1999 and 31 December 2007. Type of screening as well as codes for the location of CRCS (inpatient or outpatient) were also determined and reported. Validation studies using Medicare data shows that claims for CRCS have a sensitivity of 93-97% and a specificity of 91-95% (Schenck et al., 2007) . We assumed that the same would be true for Medicaid claims. However, the indication for testing (i.e., screening vs. diagnosis) has been unreliable in Medicare data (Schenck et al., 2007) .
To include an approximation of access to care in models, we used a primary care provider (PCP) density measure. This count was defined as the number of PCPs per 100,000 persons, as determined from the Dartmouth Atlas Project (Goodman et al., 2003) in the patients' home zip code, and was divided into quartiles.
Data analysis
We calculated the incidence of CRC as the proportion of new CRC diagnoses per 100,000 person-years. Odds ratios (OR) with 95% confidence interval (CI) compare the CRC incidence in PLWH to HIV-uninfected individuals. Multivariate logistic regression was used to calculate adjusted OR (AOR). Covariates considered included race, comorbidity index, time in the data-set, and an interaction term between race/ethnicity and HIV. Covariates were retained in the model if they caused a change in the estimate of at least 10%.
We calculated the prevalence of CRCS in both PLWH and HIV-uninfected individuals, as well as the odds of receiving CRCS in PLWH as compared to HIV-uninfected individuals. Covariates considered in the multivariate logistic regression model included race, comorbidity index, PCP density, time in the data-set, and an interaction term between race/ethnicity and HIV. Again, covariates were retained in the model if they were associated with a change in the point estimate of at least 10%.
Finally, location of CRCS and type of CRCS (barium enema, colonoscopy, or sigmoidoscopy) were compared between PLWH and HIV-uninfected patients.
Results
Analysis of CRC incidence
For the CRC incidence portion of the study, 55,439 PLWH were matched to 277,195 HIV-uninfected patients (Table 1) . PLWH were more likely to be black (42.4% vs. 19.5%) or Hispanic (24.1% vs. 22.6%). PLWH had more years in the data-set (7.98 years vs. 7.22 years), had a higher comorbidity index (7.45 vs. 3.44), and lived in places with more PCPs per 100,000 residents (80.67 vs. 77.11). There were 94 PLWH (169.6 per 100,000 personyears) and 271 HIV-uninfected patients (97.8 per 100,000 person-years) diagnosed with CRC. PLWH with CRC were diagnosed with CRC at a younger age than HIV-uninfected patients with CRC (53.51 vs. 55.68 years, p = 0.046). PLWH with CRC were more likely to be of black race than HIV-uninfected patients with CRC (37.2% vs. 21.0%, p = 0.002), while PLWH with CRC were less likely to be of "other" race/ethnicity than HIV-uninfected patients with CRC (5.3% vs. 17.0%, p = 0.002). Of those diagnosed with CRC, PLWH spent more time in the data-set (8.02 vs. 7.00 years, p < 0.001) and had a higher comorbidity index (8.97 vs. 4.72, p < 0.001). In unadjusted analyses, PLWH were more likely to have been diagnosed with CRC in 2006 (OR: 1.73, 95% CI: 1.37-2.19, p < 0.001). Only comorbidity index was retained in the model. After adjusting for comorbidity index, there was no significant relationship between HIV status and CRC diagnosis (AOR: 1.29, 95% CI: 0.98-1.70, p = 0.058).
Analysis of CRCS
In our analysis of CRCS, 22,928 PLWH were matched to 114,640 HIV-uninfected patients. PLWH were more likely to be black than those who were HIV-uninfected (44.1% vs. 18.5%) ( Table 2) . Half of the patients in each data-set were from New York State (50.7%). PLWH were in the data-set longer and had a higher comorbidity index.
Of the CRCS data-set, 35.8% of PLWH were screened compared to 33.7% of those who were uninfected. Compared to those who were uninfected, the unadjusted odds of screening in PLWH was 1.10 (95% CI: 1.07-1.13). However, after adjusting for comorbidity index and years in the data-set, PLWH had a 25% lower odds of being screened for CRC (AOR: 0.80, 95% CI: 0.77-0.83, p < 0.001).
Most patients were screened with colonoscopy (Table 3) , although this was slightly more common in HIV-uninfected patients (86.0% vs. 86.7%, p < 0.001). PLWH were more likely to have had a sigmoidoscopy (9.7% vs. 7.2%, p < 0.001).
Discussion
In this analysis of a large Medicaid data-set, we found that after adjusting for comorbidity, PLWH had similar rates of CRC as uninfected individuals. Furthermore, while PLWH were less likely to receive CRCS, the difference was small. 
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Studies on the relationship between CRC and HIV have been mixed. Many studies have suggested that PLWH were more likely to be diagnosed with CRC, often at an earlier age or with a more aggressive malignancy (Berretta et al., 2009; Bini et al., 2009; Kumar et al., 2012; Patel et al., 2008; Wasserberg et al., 2007) . However, many of these studies were singlecenter (Berretta et al., 2009; Wasserberg et al., 2007) , and most did not adjust appropriately for age. As described by Shiels, Pfeiffer, and Engels (2010) , the population of PLWH is younger than the overall population of the USA. When this group adjusted for the age difference in PLWH, they saw no difference in CRC incidence (Shiels et al., 2010) . Our study showed that when matched on age, gender, and state and after adjusting for comorbidity index, there was no increased CRC incidence among PLWH, as seen in some prior studies (Engels et al., 2008; Frisch et al., 2001; Patel et al., 2008; Silverberg et al., 2011; Van Leeuwen et al., 2009) .
Overall, PLWH were more likely to have received CRCS, but once adjusted for comorbidity index and years in the data-set, PLWH were less likely to have received CRCS. Small studies have suggested that PLWH are less likely to receive CRCS (Iqbal et al., 2010; Momplaisir et al., 2012; Reinhold et al., 2005) . However, Chang, Asch, and Werner's (2010) study of cancer screenings on obesity suggested that the presence of comorbidities may increase the likelihood of receipt of preventative screenings and vaccinations, with the possible exception of CRCS. Those with obesity may have had more clinical visits, and thus more opportunities to discuss preventative screenings (Chang et al., 2010) . Our study supports thisoverall, PLWH were more likely to receive CRCS, but this relationship no longer existed after adjusting for comorbidities and time in the data-set.
However, CRCS in this Medicaid data-set was low. In the USA, 64.5% of those over the age of 50 have received CRCS (Joseph et al., 2012) . Here, 35.8% of PLWH and 33.7% of HIV-uninfected patients received CRCS. This is actually higher than the 28.2% of eligible North Carolina Medicaid patients who have received CRCS (DuBard et al., 2008) . Patients on Medicaid are primarily of low socioeconomic status (SES) and with preexisting medical conditions (CMS, 2013) . Some of these preexisting disabilities may include psychiatric conditions which may make them less likely to agree to CRCS (Van Hout, de Wit, Rutten, & Peeters, 2011) . Patients on Medicaid may have a lower health literacy than those with employer-based insurance (Kuther, Greenberg, Jin, & Paulsen, 2006) , so may be less likely to agree to CRCS. Finally, providersincluding gastroenterologists performing CRCSmay not accept Medicaid insurance, as shown in a study of Connecticut gastroenterology practices (Patel, Nahar, Murray, & Salner, 2013) . Thus, Medicaid patients may struggle to access CRCS.
Improving the rates of CRCS in Medicaid populations is particularly important as the Affordable Care Act (ACA) will lead to an expansion in Medicaid enrollment. If Medicaid populations already have trouble accessing CRCS, policy-makers should ensure that PCPs and providers of CRCS accept more Medicaid patients. Ideas to improve health care quality overall, such as the Patient Centered Medical Home and Value-Based Purchasing, may provide opportunities for providers to improve CRCS rates among Medicaid patients.
It is possible that the low rate of CRCS in our dataset was due to the fact that half of the patients in the CRCS data-set were between the ages of 50 and 55 years. Perhaps with a few extra years, more patients would have received CRCS. However, other studies of CRCS have also looked at Americans starting at 50 years of age (DuBard et al., 2008) . In addition, we did not include claims for FOBT, since its coding in Medicaid has not been validated nor well documented. However, we felt comfortable with this decision since most Americans receive CRCS through colonoscopy, sigmoidoscopy, or barium enema (Subramanian, Klosterman, Amonkar, & Hunt, 2004) .
Our study contained other limitations as well. In using a Medicaid data-set, our patients were likely of a lower SES and possibly sicker than the overall population, so our results may not apply to PLWH, or persons in the USA, as a whole. In addition, we were unable to investigate the reasons for CRCS, as documentation of reasons for screening was inconsistent. Also, while we included five states in our study as these states represented 38% of the US Medicaid population (KFF, 2011), CRC incidence varies by state (US Cancer Statistics Working Group, 2013) . We matched by state to limit the impact of these differences on the study's main analyses. Finally, we were unable to determine from the PCP density measure whether PCPs were also HIV specialists, as HIV specialists who were midlevel providers (such as physician assistants or nurse practitioners) or physicians other than infectious diseases specialists were not well documented.
We did not investigate medication adherence in this study, as using ICD-9 codes for medication noncompliance in this setting has not been validated. While it is possible that noncompliance with ART and subsequent declining CD4 T-lymphocyte levels could lead to an increased incidence of CRC among PLWH, at least some research has failed to find a relationship between declining CD4 T-lymphocyte levels and non-ADMs with the exception of those related to infectious etiologies (Engels et al., 2008; Frisch et al., 2001; Silverberg et al., 2011) . We were unable to investigate whether ART adherence mitigates the relationship between HIV status and CRC but did not find a relationship between HIV status and CRC.
Our study is the first to examine the relationship between HIV and CRC and CRCS in a Medicaid dataset, a major provider of HIV care in the USA. We used a well-validated algorithm to identify colonoscopy and sigmoidoscopy and think that it is unlikely that a patient would have received these procedures without submitting a claim. Our data-set was large enough that we should have been able to see a relationship between HIV and CRC, or HIV and CRCS, where they existed.
In conclusion, we have demonstrated that when adjusting for comorbidities, and matched on age, gender, and state, there was no statistically significant difference in CRC incidence in PLWH and HIV-uninfected patients in a large Medicaid data-set. We also demonstrated that when adjusted for comorbidity index and time in the data-set, PLWH are less likely to receive CRCS. However, CRCS rates were very low overall, indicating that efforts are needed to improve CRCS rates in all Medicaid patients, including PLWH.
